- Home
- PD vs KTTA Comparison
PD vs KTTA Comparison
Compare PD & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PD
- KTTA
- Stock Information
- Founded
- PD 2009
- KTTA 2020
- Country
- PD United States
- KTTA United States
- Employees
- PD N/A
- KTTA N/A
- Industry
- PD Computer Software: Prepackaged Software
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- PD Technology
- KTTA Health Care
- Exchange
- PD Nasdaq
- KTTA Nasdaq
- Market Cap
- PD 1.4B
- KTTA 2.8M
- IPO Year
- PD 2019
- KTTA 2021
- Fundamental
- Price
- PD $15.99
- KTTA $0.73
- Analyst Decision
- PD Buy
- KTTA
- Analyst Count
- PD 12
- KTTA 0
- Target Price
- PD $19.50
- KTTA N/A
- AVG Volume (30 Days)
- PD 1.6M
- KTTA 164.5K
- Earning Date
- PD 09-02-2025
- KTTA 08-12-2025
- Dividend Yield
- PD N/A
- KTTA N/A
- EPS Growth
- PD N/A
- KTTA N/A
- EPS
- PD N/A
- KTTA N/A
- Revenue
- PD $476,132,000.00
- KTTA N/A
- Revenue This Year
- PD $9.60
- KTTA N/A
- Revenue Next Year
- PD $7.56
- KTTA N/A
- P/E Ratio
- PD N/A
- KTTA N/A
- Revenue Growth
- PD 8.55
- KTTA N/A
- 52 Week Low
- PD $13.70
- KTTA $0.70
- 52 Week High
- PD $22.51
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- PD 59.65
- KTTA 36.47
- Support Level
- PD $15.09
- KTTA $0.70
- Resistance Level
- PD $16.49
- KTTA $0.76
- Average True Range (ATR)
- PD 0.46
- KTTA 0.04
- MACD
- PD 0.20
- KTTA 0.01
- Stochastic Oscillator
- PD 94.64
- KTTA 21.88
About PD PagerDuty Inc.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).